Cargando…
Emergence of isolates that are intrinsically resistant to colistin in critically ill patients: are we selecting them out?
Autores principales: | Sivakumar, MN, Hisham, M, Nandakumar, V, Gopinathan, T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472744/ http://dx.doi.org/10.1186/cc14175 |
Ejemplares similares
-
Efficacy and safety of once daily dosing of colistin to critically ill patients
por: Skiada, A, et al.
Publicado: (2010) -
Pharmacokinetics of inhaled colistin in critically ill patients with ventilator-associated tracheobronchitis
por: Athanassa, Z, et al.
Publicado: (2012) -
Inhaled colistin for the treatment of ventilator-associated tracheobronchitis in critically ill patients
por: Athanassa, Z, et al.
Publicado: (2011) -
Intravenous fosfomycin therapy in critically ill patients infected with colistin-resistant enterobacteriacae
por: Mukherjee, DN, et al.
Publicado: (2015) -
Initiation of enteral and parenteral feeding and why we interrupt them in the critical care setting
por: Abi Musa Asa'ari, AKA, et al.
Publicado: (2015)